Logo image of CLH

CLEAN HARBORS INC (CLH) Stock Fundamental Analysis

NYSE:CLH - New York Stock Exchange, Inc. - US1844961078 - Common Stock - Currency: USD

226.34  +0.77 (+0.34%)

After market: 226.34 0 (0%)

Fundamental Rating

5

Taking everything into account, CLH scores 5 out of 10 in our fundamental rating. CLH was compared to 83 industry peers in the Commercial Services & Supplies industry. CLH has an average financial health and profitability rating. CLH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CLH had positive earnings in the past year.
In the past year CLH had a positive cash flow from operations.
Each year in the past 5 years CLH has been profitable.
Each year in the past 5 years CLH had a positive operating cash flow.
CLH Yearly Net Income VS EBIT VS OCF VS FCFCLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.40%, CLH is in the better half of the industry, outperforming 67.47% of the companies in the same industry.
CLH's Return On Equity of 15.21% is fine compared to the rest of the industry. CLH outperforms 73.49% of its industry peers.
CLH's Return On Invested Capital of 7.88% is fine compared to the rest of the industry. CLH outperforms 63.86% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CLH is below the industry average of 11.67%.
Industry RankSector Rank
ROA 5.4%
ROE 15.21%
ROIC 7.88%
ROA(3y)6.03%
ROA(5y)4.99%
ROE(3y)17.95%
ROE(5y)15.47%
ROIC(3y)8.67%
ROIC(5y)7.33%
CLH Yearly ROA, ROE, ROICCLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

With a decent Profit Margin value of 6.58%, CLH is doing good in the industry, outperforming 72.29% of the companies in the same industry.
In the last couple of years the Profit Margin of CLH has grown nicely.
With a decent Operating Margin value of 11.04%, CLH is doing good in the industry, outperforming 74.70% of the companies in the same industry.
CLH's Operating Margin has improved in the last couple of years.
CLH's Gross Margin of 30.76% is in line compared to the rest of the industry. CLH outperforms 49.40% of its industry peers.
In the last couple of years the Gross Margin of CLH has remained more or less at the same level.
Industry RankSector Rank
OM 11.04%
PM (TTM) 6.58%
GM 30.76%
OM growth 3Y7.87%
OM growth 5Y11.1%
PM growth 3Y8.55%
PM growth 5Y18.99%
GM growth 3Y-0.48%
GM growth 5Y0.63%
CLH Yearly Profit, Operating, Gross MarginsCLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLH is destroying value.
The number of shares outstanding for CLH remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CLH has less shares outstanding
The debt/assets ratio for CLH is higher compared to a year ago.
CLH Yearly Shares OutstandingCLH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CLH Yearly Total Debt VS Total AssetsCLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CLH has an Altman-Z score of 3.36. This indicates that CLH is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CLH (3.36) is better than 65.06% of its industry peers.
The Debt to FCF ratio of CLH is 8.22, which is on the high side as it means it would take CLH, 8.22 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.22, CLH is in the better half of the industry, outperforming 61.45% of the companies in the same industry.
A Debt/Equity ratio of 1.08 is on the high side and indicates that CLH has dependencies on debt financing.
With a Debt to Equity ratio value of 1.08, CLH is not doing good in the industry: 67.47% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 8.22
Altman-Z 3.36
ROIC/WACC0.8
WACC9.8%
CLH Yearly LT Debt VS Equity VS FCFCLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

CLH has a Current Ratio of 2.37. This indicates that CLH is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.37, CLH is doing good in the industry, outperforming 78.31% of the companies in the same industry.
A Quick Ratio of 1.98 indicates that CLH should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.98, CLH is in the better half of the industry, outperforming 79.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 1.98
CLH Yearly Current Assets VS Current LiabilitesCLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.34% over the past year.
The Earnings Per Share has been growing by 31.46% on average over the past years. This is a very strong growth
CLH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.52%.
The Revenue has been growing by 11.54% on average over the past years. This is quite good.
EPS 1Y (TTM)4.34%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-15.5%
Revenue 1Y (TTM)8.52%
Revenue growth 3Y15.67%
Revenue growth 5Y11.54%
Sales Q2Q%4.01%

3.2 Future

The Earnings Per Share is expected to grow by 12.30% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.21% on average over the next years.
EPS Next Y3.52%
EPS Next 2Y10.81%
EPS Next 3Y15.96%
EPS Next 5Y12.3%
Revenue Next Year3.85%
Revenue Next 2Y4.61%
Revenue Next 3Y5.35%
Revenue Next 5Y5.21%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLH Yearly Revenue VS EstimatesCLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
CLH Yearly EPS VS EstimatesCLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 31.35 indicates a quite expensive valuation of CLH.
CLH's Price/Earnings is on the same level as the industry average.
CLH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.34.
The Price/Forward Earnings ratio is 24.84, which indicates a rather expensive current valuation of CLH.
CLH's Price/Forward Earnings is on the same level as the industry average.
CLH is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.35
Fwd PE 24.84
CLH Price Earnings VS Forward Price EarningsCLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLH is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as CLH.
Industry RankSector Rank
P/FCF 35.83
EV/EBITDA 13.23
CLH Per share dataCLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CLH does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of CLH may justify a higher PE ratio.
CLH's earnings are expected to grow with 15.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.89
PEG (5Y)1
EPS Next 2Y10.81%
EPS Next 3Y15.96%

0

5. Dividend

5.1 Amount

No dividends for CLH!.
Industry RankSector Rank
Dividend Yield N/A

CLEAN HARBORS INC

NYSE:CLH (6/18/2025, 8:04:00 PM)

After market: 226.34 0 (0%)

226.34

+0.77 (+0.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners93.22%
Inst Owner Change-1.11%
Ins Owners5.57%
Ins Owner Change0.09%
Market Cap12.13B
Analysts81.18
Price Target257.56 (13.79%)
Short Float %1.45%
Short Ratio1.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.06%
Min EPS beat(2)1.24%
Max EPS beat(2)12.88%
EPS beat(4)3
Avg EPS beat(4)4.91%
Min EPS beat(4)-3.86%
Max EPS beat(4)12.88%
EPS beat(8)6
Avg EPS beat(8)2.12%
EPS beat(12)10
Avg EPS beat(12)9.57%
EPS beat(16)14
Avg EPS beat(16)13.49%
Revenue beat(2)0
Avg Revenue beat(2)-1.31%
Min Revenue beat(2)-1.58%
Max Revenue beat(2)-1.03%
Revenue beat(4)2
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-1.58%
Max Revenue beat(4)0.5%
Revenue beat(8)3
Avg Revenue beat(8)-1.17%
Revenue beat(12)7
Avg Revenue beat(12)0.7%
Revenue beat(16)11
Avg Revenue beat(16)2.34%
PT rev (1m)0%
PT rev (3m)-5.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.94%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.56%
Valuation
Industry RankSector Rank
PE 31.35
Fwd PE 24.84
P/S 2.04
P/FCF 35.83
P/OCF 15.94
P/B 4.72
P/tB 29.95
EV/EBITDA 13.23
EPS(TTM)7.22
EY3.19%
EPS(NY)9.11
Fwd EY4.03%
FCF(TTM)6.32
FCFY2.79%
OCF(TTM)14.2
OCFY6.27%
SpS110.96
BVpS47.99
TBVpS7.56
PEG (NY)8.89
PEG (5Y)1
Profitability
Industry RankSector Rank
ROA 5.4%
ROE 15.21%
ROCE 10.47%
ROIC 7.88%
ROICexc 8.7%
ROICexgc 14.08%
OM 11.04%
PM (TTM) 6.58%
GM 30.76%
FCFM 5.69%
ROA(3y)6.03%
ROA(5y)4.99%
ROE(3y)17.95%
ROE(5y)15.47%
ROIC(3y)8.67%
ROIC(5y)7.33%
ROICexc(3y)9.76%
ROICexc(5y)8.32%
ROICexgc(3y)16.3%
ROICexgc(5y)13.8%
ROCE(3y)11.52%
ROCE(5y)9.73%
ROICexcg growth 3Y10.92%
ROICexcg growth 5Y12.41%
ROICexc growth 3Y14.1%
ROICexc growth 5Y9.64%
OM growth 3Y7.87%
OM growth 5Y11.1%
PM growth 3Y8.55%
PM growth 5Y18.99%
GM growth 3Y-0.48%
GM growth 5Y0.63%
F-Score7
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 8.22
Debt/EBITDA 2.58
Cap/Depr 101.08%
Cap/Sales 7.1%
Interest Coverage 4.14
Cash Conversion 70.83%
Profit Quality 86.54%
Current Ratio 2.37
Quick Ratio 1.98
Altman-Z 3.36
F-Score7
WACC9.8%
ROIC/WACC0.8
Cap/Depr(3y)108.74%
Cap/Depr(5y)95.27%
Cap/Sales(3y)7.36%
Cap/Sales(5y)6.97%
Profit Quality(3y)77.75%
Profit Quality(5y)110.67%
High Growth Momentum
Growth
EPS 1Y (TTM)4.34%
EPS 3Y26.79%
EPS 5Y31.46%
EPS Q2Q%-15.5%
EPS Next Y3.52%
EPS Next 2Y10.81%
EPS Next 3Y15.96%
EPS Next 5Y12.3%
Revenue 1Y (TTM)8.52%
Revenue growth 3Y15.67%
Revenue growth 5Y11.54%
Sales Q2Q%4.01%
Revenue Next Year3.85%
Revenue Next 2Y4.61%
Revenue Next 3Y5.35%
Revenue Next 5Y5.21%
EBIT growth 1Y6.39%
EBIT growth 3Y24.78%
EBIT growth 5Y23.92%
EBIT Next Year74.71%
EBIT Next 3Y27.96%
EBIT Next 5Y20.03%
FCF growth 1Y1.22%
FCF growth 3Y3.81%
FCF growth 5Y11.72%
OCF growth 1Y9.82%
OCF growth 3Y12.52%
OCF growth 5Y13.49%